Home/Filings/4/0001437749-21-028834
4//SEC Filing

Spandow Oliver J. 4

Accession 0001437749-21-028834

CIK 0001196298other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 9:16 PM ET

Size

11.8 KB

Accession

0001437749-21-028834

Insider Transaction Report

Form 4
Period: 2021-12-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-12-14+7,0627,062 total
    Exercise: $6.82Exp: 2031-12-14Common Stock (7,062 underlying)
  • Award

    Common Stock

    2021-12-14+5,42924,829 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $5.58Exp: 2028-08-10Common Stock (9,466 underlying)
    9,466
  • Stock Option (Right to Buy)

    Exercise: $8.06Exp: 2031-01-06Common Stock (6,850 underlying)
    6,850
  • Stock Option (Right to Buy)

    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
    5,568
  • Stock Option (Right to Buy)

    Exercise: $5.85Exp: 2028-12-19Common Stock (5,161 underlying)
    5,161
Footnotes (4)
  • [F1]Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date.
  • [F2]Fully exercisable.
  • [F3]This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23.
  • [F4]Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001749836

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:16 PM ET
Size
11.8 KB